ClinConnect ClinConnect Logo
Search / Trial NCT03930147

Ventilation With ASV Mode in Children

Launched by UNIVERSITY OF LAUSANNE HOSPITALS · Apr 25, 2019

Trial Information

Current as of June 07, 2025

Completed

Keywords

Children Ventilation Closed Loop Mechanical Ventilation Adaptive Support Ventilation

ClinConnect Summary

The objective of the study is to assess the feasibility of ASV in children and compare physiologic values on ASV mode to Pressure-Control and Pressure-Support mode of ventilation regarding the participant is on active or passive ventilation phase.

Physiologic values will be monitored on different modes of ventilation in a randomized order. Each participant will be his own control regarding the different modes of ventilation. Monitoring will be done during 90 minutes for each mode of ventilation.

Participant will have two different phases of ventilation. The first one is the passive phase ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • children on invasive mechanical ventilation admitted in the Pediatric Intensive Care Unit at Lausanne University Hospital
  • Body weight \> 6kg
  • Absence of pulmonary comorbidity
  • Age \< 10 years
  • Exclusion Criteria:
  • Patient already included in other interventional clinical study
  • body weight \< 6kg
  • age \> 10 years
  • more than 20% of air leak around endotracheal tube
  • chronic or acute pulmonary disease (ARDS, cystic fibrosis, severe asthma, lobectomy, severe bronchomalacia or severe tracheomalacia)
  • severe pulmonary hypertension on inhaled nitric oxide treatment
  • severe hemodynamic instability (more than 0.5mcg/kg/min of norepinephrine infusion or other high dose vasoactive agent infusion)
  • intracranial hypertension (more than 20mmHg if measured) or suspected intracranial hypertension

About University Of Lausanne Hospitals

The University of Lausanne Hospitals (CHUV) is a leading academic medical center in Switzerland, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, CHUV focuses on translating scientific discoveries into effective treatments, fostering collaboration between researchers, healthcare professionals, and industry partners. With state-of-the-art facilities and a multidisciplinary approach, CHUV is dedicated to enhancing patient outcomes and contributing to the global body of medical knowledge through rigorous clinical trials across various therapeutic areas.

Locations

Lausanne, , Switzerland

Patients applied

0 patients applied

Trial Officials

Thomas Ferry, MD

Principal Investigator

University of Lausanne Hospitals

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials